The legacy of Viagra, and its creator copyright, presents a complex case study for investors. At first a blockbuster drug, generating billions in income, its intellectual property lapse created a flood of knock-off medications, significantly eroding its position . While certain firms may attempt to capitalize on related treatments , the current lan